IgM and IgA augmented autoantibody signatures improve early-stage detection of colorectal cancer prior to nodal and distant spread.
Md Saiful Islam RoneyCatharine LanaganYong Hua ShengKaren LawlerChristopher SchmidtNam-Trung NguyenJakob BegunGregor Stefan KijankaPublished in: Clinical & translational immunology (2021)
IgM AAbs are associated with early-stage colorectal cancer. Combining IgG, IgM and IgA AAbs is a novel strategy to improve early diagnosis of cancers.